Table 3.
Control (n = 8) |
HypWell (n = 36) |
HypPoor (n = 28) |
HypAll (n = 64) |
|
---|---|---|---|---|
Systole [mmHg] | 126 (122–132) |
129 (121–132) |
154 (146–163) ***, °°° |
137 (128–153) * |
Diastole [mmHg] | 83 (76–94) |
74 (67–77) ** |
78 (74–92) °° |
75 (70–81) * |
Age [y] | 56.0 (47.5–63.5) | 69.5 (62.0–76.0) * | 65.0 (59.0–73.0) | 66.5 (60.5–73.5) * |
Male sex | 75% | 44.4% | 64.3% | 53.1% |
BMI [kg/m2] | 27.8 (25.2–28.9) | 29.0 (26.4–33.1) | 30.4 (28.0–34.0) | 29.6 (26.8–33.8) p = 0.07 |
Smokers | 0% | 8.3% | 15.4% | 11.9% |
Diabetes mellitus | 0% | 33.3% p = 0.08 | 46.4% * | 39.1% * |
eGFR < 60 | 0% | 27.8% | 32.1% | 29.7% |
Chronic inflammatory disease a | 0% | 8.3% | 14.3% | 10.9% |
Malignancy | 0% | 16.6% | 0% ° | 9.3% |
BMI = body mass index, eGFR = estimated glomerular filtration rate. a e.g., chronic viral hepatitis and rheumatoid diseases.